BioGend Therapeutics Co Ltd

ROCO:6733 (Taiwan)   Ordinary Shares
NT$ 39.00 (+4.14%) Jun 20
At Loss
P/B:
5.15
Market Cap:
NT$ 4.85B ($ 149.82M)
Enterprise V:
NT$ 4.17B ($ 128.99M)
Volume:
1.14M
Avg Vol (2M):
195.65K
Trade In:
Volume:
1.14M
At Loss
Avg Vol (2M):
195.65K

BioGend Therapeutics Co Ltd Valuation Measures